UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

Journal of the American College of Cardiology, 2001-01, Vol.37 (1), p.169-174

2001

Volltextzugriff (PDF)

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

Drugs (New York, N.Y.), 2008-01, Vol.68 (9), p.1207-1225

Smith, David H. G.

2008

Volltextzugriff (PDF)

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Vol.5 (1), p.41-50

2005

Volltextzugriff (PDF)

Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass

American journal of hypertension, 2004, Vol.17 (1), p.37-42

2004

Volltextzugriff (PDF)

Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same?

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007-01, Vol.7 (6), p.413-422

Smith, David H G

2007

Volltextzugriff (PDF)

Evaluation of Angiotensin II Receptor Blockers for 24‐Hour Blood Pressure Control: Meta‐Analysis of a Clinical Database

The journal of clinical hypertension (Greenwich, Conn.), 2003-01, Vol.5 (1), p.58-63

2003

Volltextzugriff (PDF)

Dose-response characteristics of olmesartan medoxomil and other angiotensin receptor antagonists

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007-01, Vol.7 (5), p.347-356

Smith, David H G

2007

Volltextzugriff (PDF)

A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning

American journal of hypertension, 2001, Vol.14 (1), p.14-19

2001

Volltextzugriff (PDF)

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

American journal of hypertension, 2001-07, Vol.14 (7), p.665-671

2001

Volltextzugriff (PDF)

Pharmacology of cardiovascular chronotherapeutic agents

American journal of hypertension, 2001-09, Vol.14 (S6), p.296S-301S

Smith, David H.G

2001

Volltextzugriff (PDF)

Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade

American Journal of Hypertension, 2002-10, Vol.15 (S5), p.108S-114S

Smith, David H.G

2002

Volltextzugriff (PDF)

Low-dose combination therapy: an important first-line treatment in the management of hypertension

American journal of hypertension, 2001-03, Vol.14 (3), p.286-292

2001

Volltextzugriff (PDF)

Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action

Cardiovascular therapeutics, 2013-10, Vol.31 (5), p.251-258

2013

Volltextzugriff (PDF)

Is high blood pressure a late manifestation of the hypertension syndrome?

American journal of hypertension, 1999-12, Vol.12 (12), p.215S-223S

1999

Volltextzugriff (PDF)

Hypertension control: multifactorial contributions

American journal of hypertension, 1999-12, Vol.12 (S8), p.164S-169S

1999

Volltextzugriff (PDF)

The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities

Current opinion in nephrology and hypertension, 1997-05, Vol.6 (3), p.250-256

1997

Volltextzugriff (PDF)

Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem

American journal of hypertension, 1999-10, Vol.12 (10), p.1030-1037

1999

Volltextzugriff (PDF)

Dependency of arterial compliance on circulating neuroendocrine and metabol factors in normal subjects

The American journal of cardiology, 1992-05, Vol.69 (16), p.1340-1344

1992

Volltextzugriff (PDF)

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

Journal of hypertension, 2003-07, Vol.21 (7), p.1291-1298

2003

Volltextzugriff (PDF)

Coadministered Amlodipine and Atorvastatin Produces Early Improvements in Arterial Wall Compliance in Hypertensive Patients With Dyslipidemia

American journal of hypertension, 2009-02, Vol.22 (2), p.137-144

2009

Volltextzugriff (PDF)

A Comparison of Intravenous Nicardipine and Sodium Nitroprusside in the Immediate Treatment of Severe Hypertension

American journal of hypertension, 1994-07, Vol.7 (7-Pt-1), p.623-628

1994

Volltextzugriff (PDF)

Improving Patient Compliance: A Major Goal in the Management of Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2003-03, Vol.5 (2), p.127-132

2003

Volltextzugriff (PDF)

Treatment of hypertension with an angiotensin II—receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and enalapril

Clinical therapeutics, 2002-10, Vol.24 (10), p.1484-1501

Smith, David H.G.

2002

Volltextzugriff (PDF)

Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

The journal of clinical hypertension (Greenwich, Conn.), 2005-11, Vol.7 (11), p.641-646

2005

Volltextzugriff (PDF)

Metabolic characteristics of hypertension: Importance of positive family history

The American heart journal, 1993-10, Vol.126 (4), p.924-929

1993

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(106)

Erscheinungsjahr

n.n

Thema

Humans
(57)
Science & Technology
(51)
Life Sciences & Biomedicine
(48)
Hypertension - Drug Therapy
(35)
Male
(34)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Adult
(28)
Female
(28)
Middle Aged
(28)
Cardiovascular System & Cardiology
(27)
Hypertension
(22)
Blood Pressure - Drug Effects
(19)
Hypertension - Physiopathology
(19)
Antihypertensive Agents - Therapeutic Use
(18)
Aged
(17)
Cardiovascular System
(17)
Pharmacology. Drug Treatments
(17)
Peripheral Vascular Disease
(16)
Antihypertensive Agents
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass

Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same?

Evaluation of Angiotensin II Receptor Blockers for 24‐Hour Blood Pressure Control: Meta‐Analysis of a Clinical Database

Dose-response characteristics of olmesartan medoxomil and other angiotensin receptor antagonists

A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

Pharmacology of cardiovascular chronotherapeutic agents

Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade

Low-dose combination therapy: an important first-line treatment in the management of hypertension

Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action

Is high blood pressure a late manifestation of the hypertension syndrome?

Hypertension control: multifactorial contributions

The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities

Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem

Dependency of arterial compliance on circulating neuroendocrine and metabol factors in normal subjects

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

Coadministered Amlodipine and Atorvastatin Produces Early Improvements in Arterial Wall Compliance in Hypertensive Patients With Dyslipidemia

A Comparison of Intravenous Nicardipine and Sodium Nitroprusside in the Immediate Treatment of Severe Hypertension

Improving Patient Compliance: A Major Goal in the Management of Hypertension

Treatment of hypertension with an angiotensin II—receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and enalapril

Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

Metabolic characteristics of hypertension: Importance of positive family history

Suchergebnisse filtern